BRIEF-Bausch + Lomb and Nicox announce publication of LBN ophthalmic solution 0.024% phase 3 study results
July 6 (Reuters) - Nicox SA :
* Bausch + Lomb and Nicox announce publication of latanoprostene bunod (LBN) ophthalmic solution 0.024 pct phase 3 study results in American journal of ophthalmology
* Second published phase 3 trial to demonstrate significantly greater efficacy versus. Timolol maleate 0.5 pct Source text for Eikon: Further company coverage: (Gdynia Newsroom)
© Thomson Reuters 2017 All rights reserved.